Literature DB >> 26545070

Menière's disease.

Tony Wright1.   

Abstract

INTRODUCTION: Menière's disease causes feelings of fullness or pressure in the ear, hearing loss, tinnitus, and recurrent bouts of vertigo, and mainly affects people aged 30-60 years. Menière's disease is at first progressive but fluctuating, and episodes can occur in clusters. Vertigo usually resolves eventually, but the hearing deteriorates and the tinnitus and pressure may persist regardless of treatment. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of combination treatment (betahistine plus thiazide diuretic) to prevent attacks and delay disease progression of Menière's disease? What are the effects of intratympanic interventions to prevent attacks and delay disease progression of Menière's disease? What are the effects of non-drug interventions to prevent attacks and delay disease progression of Menière's disease? What are the effects of dietary interventions to prevent attacks and delay disease progression of Menière's disease? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2014 (Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview).
RESULTS: At this update, searching of electronic databases retrieved 200 studies. After deduplication and removal of conference abstracts, 151 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 100 studies and the further review of 51 full publications. Of the 51 full articles evaluated, five systematic reviews and four RCTs were added at this update. We performed a GRADE evaluation for eight PICO combinations.
CONCLUSIONS: In this systematic overview, we categorised the efficacy for seven interventions based on information about the effectiveness and safety of betahistine plus thiazide diuretic, caffeine restriction, intratympanic corticosteroids, intratympanic gentamicin, psychological support, salt restriction, and vestibular rehabilitation.

Entities:  

Mesh:

Year:  2015        PMID: 26545070      PMCID: PMC4636025     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  25 in total

1.  Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

2.  A new approach to surgery for Menière's disease: talking about surgery.

Authors:  A G Kerr; J G Toner
Journal:  Clin Otolaryngol Allied Sci       Date:  1998-06

3.  Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.

Authors:  Marco Antonio Garduño-Anaya; Heloísa Couthino De Toledo; Ramón Hinojosa-González; Carlo Pane-Pianese; Luis Camilo Ríos-Castañeda
Journal:  Otolaryngol Head Neck Surg       Date:  2005-08       Impact factor: 3.497

4.  Ménière's disease: lithium treatment (demonstration of placebo effect in a doubleblind cross-over trial).

Authors:  J Thomsen; P Bech; S Prytz; P Vendsborg; K Zilstorff
Journal:  Clin Otolaryngol Allied Sci       Date:  1979-04

5.  A comparative study of the aetiology of vertigo in the African.

Authors:  C Nsamba
Journal:  J Laryngol Otol       Date:  1972-09       Impact factor: 1.469

Review 6.  Outcomes of intratympanic gentamicin injection to treat Ménière's disease.

Authors:  Leh-Kiong Huon; Te-Yung Fang; Pa-Chun Wang
Journal:  Otol Neurotol       Date:  2012-07       Impact factor: 2.311

7.  Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.

Authors:  H Silverstein; J E Isaacson; M J Olds; P T Rowan; S Rosenberg
Journal:  Am J Otol       Date:  1998-03

8.  Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial.

Authors:  Robert Stokroos; Herman Kingma
Journal:  Acta Otolaryngol       Date:  2004-03       Impact factor: 1.494

9.  Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.

Authors:  Rolf J Postema; Charlotte M Kingma; Hero P Wit; Frans W J Albers; Bernard F A M Van Der Laan
Journal:  Acta Otolaryngol       Date:  2008-08       Impact factor: 1.494

10.  Natural history vs. surgery for Menière's disease.

Authors:  H Silverstein; E Smouha; R Jones
Journal:  Otolaryngol Head Neck Surg       Date:  1989-01       Impact factor: 3.497

View more
  1 in total

1.  Prevalence of Ménière's Disease in Syrian Patients with hypothyroidism: Cross-sectional study.

Authors:  Anan Bakdounes; Nawal Akashe; Mhd Obai Alchallah; Homam Alolabi; Duaa Bakdounes; Fatema Mohsen; Louei Darjazini Nahas
Journal:  Ann Med Surg (Lond)       Date:  2022-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.